Ocugen GAAP EPS of -$0.06 in-line
Source: SeekingAlpha
2026-03-04 08:17:32 ET
More on Ocugen
- Ocugen: Why I Don't Read Too Much Into The Selloff On Phase 2 GA Data
- Ocugen, Inc. (OCGN) Discusses OCU410 Phase 2 ArMaDa Trial Data and Clinical Update for Geographic Atrophy Transcript
- Ocugen: Maintaining 'Buy' Rating On Positive OCU410ST Regulatory Developments
- Ocugen Q4 2025 Earnings Preview
- Ocugen taps Rita Johnson-Greene as CFO
Read the full article on Seeking Alpha
For further details see:
Ocugen GAAP EPS of -$0.06 in-line
Ocugen, Inc.
NASDAQ: OCGN
OCGN Trading
-5.03% G/L:
$1.64 Last:
2,843,898 Volume:
$1.74 Open:
OCGN Latest News
March 04, 2026 08:15:00 am
Ocugen Provides Business Update with Fourth Quarter and Full Year 2025 Financial Results
OCGN Stock Data
$478,717,026
313,395,708
0.26%
38
N/A
Biotechnology & Life Sciences
Healthcare
US
Malvern
